Literature DB >> 10654015

Immune reconstitution and outcome after unrelated cord blood transplantation: a single paediatric institution experience.

P Giraud1, I Thuret, D Reviron, H Chambost, C Brunet, G Novakovitch, C Farnarier, G Michel.   

Abstract

We report the outcome of 12 children who underwent unrelated cord blood transplant (U-CBT) in a single institution between February 1997 and July 1998. The 1 year event-free survival was 67% (95% CI of 26%). Four children died with infectious complication as cause of death in three cases. Immune reconstitution was studied during first year post transplant by assaying total lymphocyte counts, B cells, NK cells and T cell subsets in the eight disease-free surviving patients. We observed a prompt recovery of CD19+ cell number which was greater than 500/microl at 9 months for all patients except the one with severe cGVHD. B cells constituted the predominant lymphocyte subset at 6 and 9 months post transplant with normal or elevated B cell numbers according to normal paediatric range. We noted normal serum immunoglobulin levels at 6 months post transplant for IgA and IgM and at 9 months for IgG. The CD3+ cell count and particularly the CD3+CD8+ T cell subset remained depressed until 12 months post transplant. Six months after unrelated CBT, seven out of eight patients had less than 100 CD3+CD8+ cells/microl. CD3+CD4+ cell recovery was less impaired with all children achieving an absolute count of CD3+CD4+ cells greater than 200/microl during the first year in a median of 5 months. The percentage of NK cells was elevated during the first 6 months after CBT but their absolute count remained within the normal range. Bone Marrow Transplantation (2000) 25, 53-57.

Entities:  

Mesh:

Year:  2000        PMID: 10654015     DOI: 10.1038/sj.bmt.1702089

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  6 in total

1.  Umbilical cord blood transplantation is a suitable option for consolidation of acute myeloid leukemia with FLT3-ITD.

Authors:  Craig E Eckfeldt; Nicole Randall; Ryan M Shanley; Sophia Yohe; Nelli Bejanyan; Michelle Dolan; Erica D Warlick; Michael R Verneris; Claudio G Brunstein; John E Wagner; Daniel J Weisdorf; Celalettin Ustun
Journal:  Haematologica       Date:  2016-04-28       Impact factor: 9.941

Review 2.  Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution.

Authors:  Julia A Brown; Vassiliki A Boussiotis
Journal:  Clin Immunol       Date:  2008-04-18       Impact factor: 3.969

3.  Factors influencing lymphocyte reconstitution after allogeneic hematopoietic stem cell transplantation in children.

Authors:  Keun Wook Bae; Bo Eun Kim; Kyung Nam Koh; Ho Joon Im; Jong Jin Seo
Journal:  Korean J Hematol       Date:  2012-03-28

4.  Abnormal expansion of naïve B lymphocytes after unrelated cord blood transplantation--a case report.

Authors:  Y Shono; T Toubai; S Ota; M Ibata; S Mashiko; D Hirate; Y Miura; S Umehara; N Toyoshima; J Tanaka; M Asaka; M Imamura
Journal:  Clin Lab Haematol       Date:  2006-10

5.  A potential role for B cells in suppressed immune responses in cord blood transplant recipients.

Authors:  B C Beaudette-Zlatanova; P T Le; K L Knight; S Zhang; S Zakrzewski; M Parthasarathy; P J Stiff
Journal:  Bone Marrow Transplant       Date:  2012-06-25       Impact factor: 5.483

6.  Infectious Complications After Umbilical Cord Blood Transplantation for Hematological Malignancy.

Authors:  Kathleen A Linder; Philip J McDonald; Carol A Kauffman; Sanjay G Revankar; Pranatharthi H Chandrasekar; Marisa H Miceli
Journal:  Open Forum Infect Dis       Date:  2019-02-22       Impact factor: 3.835

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.